Skip to content

Effects of telepractice in Speech and Language Pathology on orofacial myofascial pain

Effects of telecare focusing on chewing and swallowing functions on orofacial myofascial pain

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-8f8yk8h
Enrollment
Unknown
Registered
2022-04-12
Start date
2021-01-17
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Temporomandibular joint

Interventions

Group 1 Intervention (21 participants): orofacial myofunctional therapy focusing on chewing and swallowing and general guidelines on pain education, orally and in writing. Group 2 Control (21 particip
SP2.021.167.010.090.270

Sponsors

Universidade Federal de Minas Gerais - UFMG
Lead Sponsor
Pontifícia Universidade Católica de Minas Gerais - PUC Minas
Collaborator

Eligibility

Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Diagnosis of orofacial myofascial pain with spreading or referred according to CD-TMD (Diagnostic Criteria for Temporomandibular Disorders); age between 18 and 30 years; pain intensity higher then 4 by the numerical visual scale for at least 3 months prior to recruitment, having access to internet and the platform that will be used for teleterapy, signing the free and informed consent form (ICF).

Exclusion criteria

Exclusion criteria: Gestation; absence of central and lateral incisor teeth; presence of: dental pain, periodontal changes, previous or current tumor or major trauma in the head and neck region, edentulism, use of complete dentures and current orthodontics; diagnosis of fibromyalgia; presence of arthralgia, current myofunctional treatment or any other type of treatment for temporomandibular disorders; treatment for sleep disorders; continuous use of non-steroidal anti-inflammatory drugs, analgesics, antidepressants or central myorelaxant drugs; use of bronchodilators and vasoactive medications; presence of fever, allergic rhinitis, flu and/or cold symptoms; presence of neurological or cognitive impairments; use of a bandage on the skin and/or other factors that prevent its exposure to a balanced temperature environment at the time of data collection; performing physical exercises, acupuncture, massages, electrical stimulation, having attended saunas or being exposed to the sun for a long time on the day of the evaluation; not agreeing to participate in the research and refusing to sign the informed consent, as well as not carrying out the activities requested at the time of evaluation and therapy.

Design outcomes

Primary

MeasureTime frame
Improvement of orofacial myofascial pain, assessed by visual numerical scale and pressure algometry. Data collected before the intervention, in the week after the last treatment session, after one month of the final reassessment and after three months of the end of the treatment.

Secondary

MeasureTime frame
Improvement in orofacial myofunctional assessment scores and in the diagnostic criteria for temporomandibular disorders, difference in temperature between the hemifaces in the regions of interest and balance of the values of facial symmetry indices in the regions of interest respectively: OMES-protocol (Orofacial myofunctional evaluation with scores), DC-TMD (Diagnostic Criteria for Temporomandibular Disorders), infrared thermography and surface electromyography measured in the following week after the last treatment session, one month after the final reassessment and three months after the end of the treatment.

Countries

Brazil

Contacts

Public ContactAndréa Motta

Universidade Federal de Minas Gerais - UFMG

andreamotta19@gmail.com+55 31 999580676

Outcome results

None listed

Source: REBEC (via WHO ICTRP)